{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:36:26Z","timestamp":1774492586867,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Following the strong recommendation for coronavirus disease 2019 (COVID\u201119) vaccination, many patients with medical comorbidities are being immunized. However, the safety of vaccination in patients with autoimmune diseases has not been well established. We report a new case of biopsy-proven IgA vasculitis with nephritis presenting as a nephrotic syndrome after mRNA COVID-19 vaccination in a patient with a history of leukocytoclastic vasculitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 76-year-old man with a history of cutaneous leukocytoclastic vasculitis presented with purpura in both lower limbs, followed by nephrotic syndrome after the second dose of BNT162b2 mRNA COVID-19 vaccination. Skin and renal biopsy revealed IgA vasculitis with nephritis. The patient\u2019s past medical history of leukocytoclastic vasculitis and features of chronicity in renal pathology suggest an acute exacerbation of preexisting IgA vasculitis after COVID-19 vaccination. After the steroid and renin-angiotensin system inhibitor use, purpura and acute kidney injury recovered within a month. Subnephrotic proteinuria with microscopic hematuria remained upon follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Physicians should keep in mind the potential (re)activation of IgA vasculitis following mRNA COVID-19 vaccines. It is important to closely monitor COVID-19 vaccinated patients, particularly those with autoimmune diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-03028-7","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T08:03:19Z","timestamp":1671091399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["IgA vasculitis presenting as nephrotic syndrome following COVID-19 vaccination: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Illeon","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jwa-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5034-0527","authenticated-orcid":false,"given":"Sung Gyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"issue":"4","key":"3028_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","volume":"21","author":"JR Teijaro","year":"2021","unstructured":"Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021;21(4):195\u20137.","journal-title":"Nat Rev Immunol"},{"issue":"7830","key":"3028_CR2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","volume":"586","author":"U Sahin","year":"2020","unstructured":"Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T. Nature. 2020;586(7830):594\u20139.","journal-title":"Nature"},{"issue":"6","key":"3028_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1159\/000524619","volume":"146","author":"L Martinez Valenzuela","year":"2022","unstructured":"Martinez Valenzuela L, Oliveras L, Gom\u00e0 M, et al. Th1 cytokines signature in 2 cases of IgA nephropathy flare after mRNA-based SARS-CoV-2 vaccine: exploring the pathophysiology. Nephron. 2022;146(6):564\u201372. https:\/\/doi.org\/10.1159\/000524619.","journal-title":"Nephron."},{"issue":"27","key":"3028_CR4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"5","key":"3028_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316.","journal-title":"N Engl J Med"},{"issue":"4","key":"3028_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa2107058","volume":"385","author":"MG Thompson","year":"2021","unstructured":"Thompson MG, Burgess JL, Naleway AL, Tyner H, Yoon SK, Meece J, et al. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines. N Engl J Med. 2021;385(4):320\u20139.","journal-title":"N Engl J Med"},{"issue":"15","key":"3028_CR7","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","volume":"384","author":"N Dagan","year":"2021","unstructured":"Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA Covid-19 vaccine in a Nationwide Mass Vaccination setting. N Engl J Med. 2021;384(15):1412\u201323.","journal-title":"N Engl J Med"},{"issue":"5","key":"3028_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.kint.2021.09.002","volume":"100","author":"NL Li","year":"2021","unstructured":"Li NL, Coates PT, Rovin BH. COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation? Kidney Int. 2021;100(5):959\u201365.","journal-title":"Kidney Int"},{"issue":"12","key":"3028_CR9","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.ekir.2021.09.008","volume":"6","author":"N Klomjit","year":"2021","unstructured":"Klomjit N, Alexander MP, Fervenza FC, Zoghby Z, Garg A, Hogan MC, et al. COVID-19 vaccination and glomerulonephritis. Kidney Int Rep. 2021;6(12):2969\u201378.","journal-title":"Kidney Int Rep"},{"key":"3028_CR10","doi-asserted-by":"publisher","unstructured":"Ma Y, Xu G. New-onset IgA nephropathy following COVID-19 vaccination [published online ahead of print, 2022 Aug 3] [published correction appears in QJM. 2022 Oct 22;:]. QJM. 2022;hcac185. https:\/\/doi.org\/10.1093\/qjmed\/hcac185.","DOI":"10.1093\/qjmed\/hcac185"},{"issue":"6","key":"3028_CR11","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.kint.2021.03.002","volume":"99","author":"L Negrea","year":"2021","unstructured":"Negrea L, Rovin BH. Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy. Kidney Int. 2021;99(6):1487.","journal-title":"Kidney Int"},{"issue":"1","key":"3028_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.kint.2021.04.024","volume":"100","author":"SEG Rahim","year":"2021","unstructured":"Rahim SEG, Lin JT, Wang JC. A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination. Kidney Int. 2021;100(1):238.","journal-title":"Kidney Int"},{"issue":"2","key":"3028_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.kint.2021.05.022","volume":"100","author":"P Perrin","year":"2021","unstructured":"Perrin P, Bassand X, Benotmane I, Bouvier N. Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy. Kidney Int. 2021;100(2):466\u20138.","journal-title":"Kidney Int"},{"issue":"2","key":"3028_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.kint.2021.05.009","volume":"100","author":"HZ Tan","year":"2021","unstructured":"Tan HZ, Tan RY, Choo JCJ, Lim CC, Tan CS, Loh AHL, et al. Is COVID-19 vaccination unmasking glomerulonephritis? Kidney Int. 2021;100(2):469\u201371.","journal-title":"Kidney Int"},{"issue":"2","key":"3028_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.kint.2021.06.011","volume":"100","author":"S Kudose","year":"2021","unstructured":"Kudose S, Friedmann P, Albajrami O, D\u2019Agati VD. Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy. Kidney Int. 2021;100(2):468\u20139.","journal-title":"Kidney Int"},{"issue":"2","key":"3028_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.kint.2021.05.016","volume":"100","author":"MA Anderegg","year":"2021","unstructured":"Anderegg MA, Liu M, Saganas C, Montani M, Vogt B, Huynh-Do U, et al. De novo vasculitis after mRNA-1273 (Moderna) vaccination. Kidney Int. 2021;100(2):474\u20136.","journal-title":"Kidney Int"},{"issue":"3","key":"3028_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.kint.2021.06.032","volume":"100","author":"C Hanna","year":"2021","unstructured":"Hanna C, Herrera Hernandez LP, Bu L, Kizilbash S, Najera L, Rheault MN, et al. IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine. Kidney Int. 2021;100(3):705\u20136.","journal-title":"Kidney Int"},{"issue":"4","key":"3028_CR18","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.kint.2021.07.020","volume":"100","author":"R Plasse","year":"2021","unstructured":"Plasse R, Nee R, Gao S, Olson S. Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination. Kidney Int. 2021;100(4):944\u20135.","journal-title":"Kidney Int"},{"issue":"8","key":"3028_CR19","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1016\/j.ekir.2021.06.007","volume":"6","author":"K Park","year":"2021","unstructured":"Park K, Miyake S, Tai C, Tseng M, Andeen NK, Kung VL. \u201cA case of Gross Hematuria and IgA Nephropathy Flare-Up following SARS-CoV-2 Vaccination\u201d. Kidney Int Rep. 2021;6(8):2246\u20137.","journal-title":"Kidney Int Rep"},{"issue":"5","key":"3028_CR20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.xkme.2021.05.002","volume":"3","author":"M Abramson","year":"2021","unstructured":"Abramson M, Mon-Wei Yu S, Campbell KN, Chung M, Salem F. IgA Nephropathy after SARS-CoV-2 vaccination. Kidney Med. 2021;3(5):860\u20133.","journal-title":"Kidney Med"},{"issue":"10","key":"3028_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/qjmed\/hcab223","volume":"114","author":"T Horino","year":"2021","unstructured":"Horino T. IgA nephropathy flare-up following SARS-CoV-2 vaccination. QJM. 2021;114(10):735\u20136.","journal-title":"QJM"},{"issue":"4","key":"3028_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s13730-022-00695-1","volume":"11","author":"K Sugita","year":"2022","unstructured":"Sugita K, Kaneko S, Hisada R, Harano M, Anno E, Hagiwara S, et al. Development of IgA vasculitis with severe glomerulonephritis after COVID-19 vaccination: a case report and literature review. CEN Case Rep. 2022;11(4):436\u201341.","journal-title":"CEN Case Rep"},{"issue":"3","key":"3028_CR23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s13730-021-00677-9","volume":"11","author":"S Nakatani","year":"2022","unstructured":"Nakatani S, Mori K, Morioka F, Hirata C, Tsuda A, Uedono H, et al. New-onset kidney biopsy-proven IgA vasculitis after receiving mRNA-1273 COVID-19 vaccine: case report. CEN Case Rep. 2022;11(3):358\u201362.","journal-title":"CEN Case Rep"},{"issue":"1","key":"3028_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/qjmed\/hcab305","volume":"115","author":"T Horino","year":"2022","unstructured":"Horino T, Sawamura D, Inotani S, Ishihara M, Komori M, Ichii O. Newly diagnosed IgA nephropathy with gross haematuria following COVID-19 vaccination. QJM. 2022;115(1):28\u20139.","journal-title":"QJM"},{"issue":"1","key":"3028_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.23876\/j.krcp.21.233","volume":"41","author":"JS Park","year":"2022","unstructured":"Park JS, Lee EY. Renal side effects of COVID-19 vaccines in patients with immunoglobulin A nephropathy. Kidney Res Clin Pract. 2022;41(1):124\u20137.","journal-title":"Kidney Res Clin Pract"},{"issue":"2","key":"3028_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00467-021-05351-x","volume":"37","author":"O Niel","year":"2022","unstructured":"Niel O, Florescu C. IgA nephropathy presenting as rapidly progressive glomerulonephritis following first dose of COVID-19 vaccine. Pediatr Nephrol. 2022;37(2):461\u20132.","journal-title":"Pediatr Nephrol"},{"issue":"18","key":"3028_CR27","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1016\/j.vaccine.2022.03.003","volume":"40","author":"DH Abdel-Qader","year":"2022","unstructured":"Abdel-Qader DH, Hazza Alkhatatbeh I, Hayajneh W, Annab H, Al Meslamani AZ, Elmusa RA. IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine. Vaccine. 2022;40(18):2528\u201330.","journal-title":"Vaccine"},{"issue":"3","key":"3028_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s13730-021-00679-7","volume":"11","author":"M Okada","year":"2022","unstructured":"Okada M, Kikuchi E, Nagasawa M, Oshiba A, Shimoda M. An adolescent girl diagnosed with IgA nephropathy following the first dose of the COVID-19 vaccine. CEN Case Rep. 2022;11(3):376\u20139.","journal-title":"CEN Case Rep"},{"issue":"3","key":"3028_CR29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s13730-021-00670-2","volume":"11","author":"Y Fujita","year":"2022","unstructured":"Fujita Y, Yoshida K, Ichikawa D, Shibagaki Y, Yazawa M. Abrupt worsening of occult IgA nephropathy after the first dose of SARS-CoV-2 vaccination. CEN Case Rep. 2022;11(3):302\u20138.","journal-title":"CEN Case Rep"},{"issue":"1","key":"3028_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/nep.13992","volume":"27","author":"WK Lo","year":"2022","unstructured":"Lo WK, Chan KW. Gross haematuria after mRNA COVID-19 vaccination in two patients with histological and clinical diagnosis of IgA nephropathy. Nephrol (Carlton). 2022;27(1):110\u20131.","journal-title":"Nephrol (Carlton)"},{"issue":"3","key":"3028_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/ckj\/sfab241","volume":"15","author":"LC Leong","year":"2022","unstructured":"Leong LC, Hong WZ, Khatri P. Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination. Clin Kidney J. 2022;15(3):569\u201370.","journal-title":"Clin Kidney J"},{"issue":"2","key":"3028_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/vaccines10020302","volume":"10","author":"JH Lim","year":"2022","unstructured":"Lim JH, Kim MS, Kim YJ, Han MH, Jung HY, Choi JY, et al. New-onset kidney diseases after COVID-19 vaccination: a case series. Vaccines (Basel). 2022;10(2):302.","journal-title":"Vaccines (Basel)."},{"issue":"3","key":"3028_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5414\/CN110689","volume":"97","author":"V Srinivasan","year":"2022","unstructured":"Srinivasan V, Geara AS, Han S, Hogan JJ, Coppock G. Need for symptom monitoring in IgA nephropathy patients post COVID-19 vaccination. Clin Nephrol. 2022;97(3):193\u20134.","journal-title":"Clin Nephrol"},{"issue":"7","key":"3028_CR34","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00467-022-05518-0","volume":"37","author":"K Morisawa","year":"2022","unstructured":"Morisawa K, Honda M. Two patients presenting IgA nephropathy after COVID-19 vaccination during a follow-up for asymptomatic hematuria. Pediatr Nephrol. 2022;37(7):1695\u20136.","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"3028_CR35","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2169\/internalmedicine.8787-21","volume":"61","author":"Y Nihei","year":"2022","unstructured":"Nihei Y, Kishi M, Suzuki H, Koizumi A, Yoshida M, Hamaguchi S, et al. IgA Nephropathy with Gross Hematuria following COVID-19 mRNA vaccination. Intern Med. 2022;61(7):1033\u20137.","journal-title":"Intern Med"},{"issue":"4","key":"3028_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s13730-022-00707-0","volume":"11","author":"S Yokote","year":"2022","unstructured":"Yokote S, Ueda H, Shimizu A, Okabe M, Yamamoto K, Tsuboi N, et al. IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases. CEN Case Rep. 2022;11(4):499\u2013505.","journal-title":"CEN Case Rep"},{"issue":"1","key":"3028_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12882-022-02843-2","volume":"23","author":"Y Uchiyama","year":"2022","unstructured":"Uchiyama Y, Fukasawa H, Ishino Y, Nakagami D, Kaneko M, Yasuda H, et al. Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following SARS-CoV-2 vaccination. BMC Nephrol. 2022;23(1):216.","journal-title":"BMC Nephrol"},{"issue":"1","key":"3028_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12882-022-02769-9","volume":"23","author":"S Watanabe","year":"2022","unstructured":"Watanabe S, Zheng S, Rashidi A. IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report. BMC Nephrol. 2022;23(1):135.","journal-title":"BMC Nephrol"},{"issue":"7","key":"3028_CR39","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00467-022-05517-1","volume":"37","author":"T Udagawa","year":"2022","unstructured":"Udagawa T, Motoyoshi Y. Macroscopic hematuria in two children with IgA nephropathy remission following Pfizer COVID-19 vaccination. Pediatr Nephrol. 2022;37(7):1693\u20134.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"3028_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5414\/CN110794","volume":"97","author":"T Schaubschlager","year":"2022","unstructured":"Schaubschlager T, Rajora N, Diep S, Kirtek T, Cai Q, Hendricks AR, et al. De novo or recurrent glomerulonephritis and acute tubulointerstitial nephritis after COVID-19 vaccination: a report of six cases from a single center. Clin Nephrol. 2022;97(5):289\u201397.","journal-title":"Clin Nephrol"},{"issue":"11","key":"3028_CR41","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/sj.ki.5000419","volume":"69","author":"J Barratt","year":"2006","unstructured":"Barratt J, Feehally J. Treatment of IgA nephropathy. Kidney Int. 2006;69(11):1934\u20138.","journal-title":"Kidney Int"},{"issue":"3","key":"3028_CR42","doi-asserted-by":"publisher","first-page":"104035","DOI":"10.1016\/j.lpm.2020.104035","volume":"49","author":"F Maritati","year":"2020","unstructured":"Maritati F, Canzian A, Fenaroli P, Vaglio A. Adult-onset IgA vasculitis (Henoch-Sch\u00f6nlein): update on therapy. Presse Med. 2020;49(3):104035.","journal-title":"Presse Med"},{"issue":"4S","key":"3028_CR43","first-page":"1","volume":"100","author":"KDIGOKGDW Group","year":"2021","unstructured":"Group KDIGOKGDW. KDIGO 2021 Clinical Practice Guideline for the management of glomerular Diseases. Kidney Int. 2021;100(4S):1\u2013276.","journal-title":"Kidney Int"},{"key":"3028_CR44","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","volume":"217","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480.","journal-title":"Clin Immunol"},{"key":"3028_CR45","doi-asserted-by":"publisher","first-page":"617089","DOI":"10.3389\/fimmu.2020.617089","volume":"11","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for Autoimmune Diseases. Front Immunol. 2020;11:617089.","journal-title":"Front Immunol"},{"issue":"4","key":"3028_CR46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00467-021-04950-y","volume":"37","author":"MC Hastings","year":"2022","unstructured":"Hastings MC, Rizk DV, Kiryluk K, Nelson R, Zahr RS, Novak J, et al. IgA vasculitis with nephritis: update of pathogenesis with clinical implications. Pediatr Nephrol. 2022;37(4):719\u201333.","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"3028_CR47","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.ekir.2020.08.016","volume":"5","author":"AS Suso","year":"2020","unstructured":"Suso AS, Mon C, O\u00f1ate Alonso I, Galindo Romo K, Juarez RC, Ram\u00edrez CL, et al. IgA Vasculitis with Nephritis (Henoch-Sch\u00f6nlein Purpura) in a COVID-19 patient. Kidney Int Rep. 2020;5(11):2074\u20138.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"3028_CR48","doi-asserted-by":"publisher","first-page":"e14551","DOI":"10.1111\/dth.14551","volume":"34","author":"S Sandhu","year":"2021","unstructured":"Sandhu S, Chand S, Bhatnagar A, Dabas R, Bhat S, Kumar H, et al. Possible association between IgA vasculitis and COVID-19. Dermatol Ther. 2021;34(1):e14551.","journal-title":"Dermatol Ther"},{"issue":"Suppl 129","key":"3028_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.55563\/clinexprheumatol\/5epvob","volume":"39","author":"L Barbetta","year":"2021","unstructured":"Barbetta L, Filocamo G, Passoni E, Boggio F, Folli C, Monzani V. Henoch-Sch\u00f6nlein purpura with renal and gastrointestinal involvement in course of COVID-19: a case report. Clin Exp Rheumatol. 2021;39(Suppl 129(2):191\u20132.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"3028_CR50","doi-asserted-by":"publisher","first-page":"e239910","DOI":"10.1136\/bcr-2020-239910","volume":"14","author":"DA AlGhoozi","year":"2021","unstructured":"AlGhoozi DA, AlKhayyat HM. A child with Henoch-Schonlein purpura secondary to a COVID-19 infection. BMJ Case Rep. 2021;14(1):e239910.","journal-title":"BMJ Case Rep"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-03028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-03028-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-03028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T09:03:50Z","timestamp":1671095030000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-03028-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-03028-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"5 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient approved of publishing this manuscript and signed a written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}